Sue Edwards

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

Mark S. Graham, Carole H. Sudre, Anna May et al. · The Lancet Public Health · 2021 · 343 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +12

Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment

Yeyejide Adeleye, Melvin E. Andersen, Rebecca A. Clewell et al. · Toxicology · 2014 · 126 citations · Full text

Pharmacy, Toxicology, Mechanisms Of Toxicity +14

The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

Thushan I. de Silva, Guihai Liu, Benjamin B. Lindsey et al. · iScience · 2021 · 92 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study

Kerstin Kläser, Erika Molteni, Mark S. Graham et al. · Scientific Reports · 2022 · 68 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission

Dinesh Aggarwal, Ben Warne, Aminu S. Jahun et al. · Nature Communications · 2022 · 52 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17